Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Blood Specimen Collection 123Surveys and Questionnaires 82Observation 49Radiotherapy 40Surgical Procedures, Operative 34Drug Therapy 34Biopsy 31Specimen Handling 28Data Collection 27Watchful Waiting 20Interviews as Topic 20Magnetic Resonance Imaging 18Immune Checkpoint Inhibitors 17Liquid Biopsy 16Magnetic Resonance Spectroscopy 15Immunotherapy 15Standard of Care 13pembrolizumab 12Tomography, X-Ray Computed 12Ultrasonography 11trastuzumab deruxtecan 10lenvatinib 10Radiosurgery 10Nivolumab 10Neoadjuvant Therapy 10Carboplatin 10Tissue Banks 9Restraint, Physical 9Radiation 9Endoscopy 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Observational × ensartinib × Clear all
NCT05498064 2022-08-11

A Real World Study of Ensartinib in Advanced ALK-positive NSCLC

Peking Union Medical College Hospital

Recruiting
490 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡